Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Coursaget

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Presse Medicale (Paris, France : 1983)|December 3, 2014
Viruses associated with skin and mucosal cancersPierre Coursaget
Salud Publica De Mexico|January 30, 2004
Serology for human papillomavirusPierre Coursaget
Presse Medicale (Paris, France : 1983)|September 22, 2009
[HPV immunization for the prevention of cervical cancer]Christiane Mougin, Isabelle Bourgault-Villada, Pierre Coursaget
Journal of Medical Virology|June 2, 2004
Positively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivityLatifa Bousarghin, Antoine Touzé, Bernard Yvonnet, et al.
Molecular Biotechnology|March 19, 2014
Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapyMaxime J J Fleury, Antoine Touzé, Pierre Coursaget
Journal of Virology|March 1, 2003
Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cellsLatifa Bousarghin, Antoine Touzé, Pierre-Yves Sizaret, et al.
The Journal of General Virology|January 21, 2003
Positively charged sequences of human papillomavirus type 16 capsid proteins are sufficient to mediate gene transfer into target cells via the heparan sulfate receptorLatifa Bousarghin, Antoine Touzé, Alba-Lucia Combita-Rojas, et al.
Vaccine|September 5, 2006
Chapter 15: HPV vaccine use in the developing worldMark A Kane, Jacqueline Sherris, Pierre Coursaget, et al.
Journal of Virology|June 7, 2002
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomavirusesAlba-Lucia Combita, Antoine Touzé, Latifa Bousarghin, et al.
International Journal of Cancer|February 22, 2002
Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancerAlba-Lucia Combita, Maria-Mercedes Bravo, Antoine Touzé, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Presse Medicale (Paris, France : 1983)|December 3, 2014
Viruses associated with skin and mucosal cancersPierre Coursaget
Salud Publica De Mexico|January 30, 2004
Serology for human papillomavirusPierre Coursaget
Presse Medicale (Paris, France : 1983)|September 22, 2009
[HPV immunization for the prevention of cervical cancer]Christiane Mougin, Isabelle Bourgault-Villada, Pierre Coursaget
Journal of Medical Virology|June 2, 2004
Positively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivityLatifa Bousarghin, Antoine Touzé, Bernard Yvonnet, et al.
Molecular Biotechnology|March 19, 2014
Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapyMaxime J J Fleury, Antoine Touzé, Pierre Coursaget
Journal of Virology|March 1, 2003
Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cellsLatifa Bousarghin, Antoine Touzé, Pierre-Yves Sizaret, et al.
The Journal of General Virology|January 21, 2003
Positively charged sequences of human papillomavirus type 16 capsid proteins are sufficient to mediate gene transfer into target cells via the heparan sulfate receptorLatifa Bousarghin, Antoine Touzé, Alba-Lucia Combita-Rojas, et al.
Vaccine|September 5, 2006
Chapter 15: HPV vaccine use in the developing worldMark A Kane, Jacqueline Sherris, Pierre Coursaget, et al.
Journal of Virology|June 7, 2002
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomavirusesAlba-Lucia Combita, Antoine Touzé, Latifa Bousarghin, et al.
International Journal of Cancer|February 22, 2002
Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancerAlba-Lucia Combita, Maria-Mercedes Bravo, Antoine Touzé, et al.
Pageof 6